Itsuko Ishii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Itsuko Ishii has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Masashi Uchida
Departments of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan; Division of Pharmacy, Chiba University Hospital, Chiba, Japan
5 shared publicationsTakaaki Suzuki
Division of Pharmacy, Chiba University Hospital, Chiba, Japan
4 shared publicationsMasachika Fujiyoshi
Departments of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
3 shared publicationsKenta Watanabe
Division of Pharmacy, Chiba University Hospital, Chiba, Japan
2 shared publicationsBalkrishna Khakurel
Department of Drug Administration; Kathmandu Nepal
1 shared publicationBhupendra Kumar Poudel
Graduate School of Pharmaceutical Sciences; Chiba University; Chiba Japan
1 shared publication
Latest Publications
- 1 December 2024
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 144 (12) , 1095-1099
The Role of Laboratory Data on Outpatient Prescriptions in Improving Collaboration with the Community and Health Outcomes
Although there have been appeals for regional cooperation for a considerable time, are hospitals and local communities really working together? Hospitals typically permit a variety of professionals to work together, share information via medical records, and directly discuss patients. A problem with treating patients at home in local communities is that doctors and pharmacists do not share the same workplace; hospitals, clinics, and pharmacies do not have a common information source equivalent to medical records. Prescriptions and medical notes are the only things that connect health provision to the community. We have added laboratory data to prescriptions for outpatients to eliminate confusion. This has improved efficacy and made it easier to avoid serious side effects. It has also prevented economic losses to some extent. An important goal of medicine is to provide individualized care. This current endeavor may be a small but steady step towards this goal.
- 1 December 2024
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 144 (12) , 1095-1099
The Role of Laboratory Data on Outpatient Prescriptions in Improving Collaboration with the Community and Health Outcomes
Although there have been appeals for regional cooperation for a considerable time, are hospitals and local communities really working together? Hospitals typically permit a variety of professionals to work together, share information via medical records, and directly discuss patients. A problem with treating patients at home in local communities is that doctors and pharmacists do not share the same workplace; hospitals, clinics, and pharmacies do not have a common information source equivalent to medical records. Prescriptions and medical notes are the only things that connect health provision to the community. We have added laboratory data to prescriptions for outpatients to eliminate confusion. This has improved efficacy and made it easier to avoid serious side effects. It has also prevented economic losses to some extent. An important goal of medicine is to provide individualized care. This current endeavor may be a small but steady step towards this goal.
- Open Access
- 26 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1819
Development of an Alcohol Dilution–Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability
The lipid nanoparticle (LNP) is one of the promising nanotechnologies for the delivery of RNA molecules, such as small interfering RNA (siRNA) and messenger RNA (mRNA). A series of LNPs that contain an mRNA encoding the antigen protein of SARS-CoV-2 were already approved as RNA vaccines against this infectious disease. Since LNP formulations are generally metastable, their physicochemical properties are expected to shift toward a more stable state during the long-time storage of suspensions. The current mRNA vaccines are supplied in the form of frozen formulations with a cryoprotectant for preventing deterioration. They must be stored in a freezer at temperatures from −80 °C to −15 °C. It is thought that therapeutic applications of this mRNA-LNP technology could be accelerated if a new formulation that permits mRNA-LNPs to be stored under milder conditions were available. We previously reported on a one-pot method for producing siRNA-encapsulated LNPs by combining freeze-drying technology with the conventional alcohol dilution method (referred to herein as the “alcohol dilution–lyophilization method”). In this study, this method was applied to the preparation of mRNA-LNPs to provide a freeze-dried formulation of mRNA LNPs. The resulting formulation can be stored at 4 °C for at least 4 months.
- 26 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1819
Open AccessDevelopment of an Alcohol Dilution–Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability
The lipid nanoparticle (LNP) is one of the promising nanotechnologies for the delivery of RNA molecules, such as small interfering RNA (siRNA) and messenger RNA (mRNA). A series of LNPs that contain an mRNA encoding the antigen protein of SARS-CoV-2 were already approved as RNA vaccines against this infectious disease. Since LNP formulations are generally metastable, their physicochemical properties are expected to shift toward a more stable state during the long-time storage of suspensions. The current mRNA vaccines are supplied in the form of frozen formulations with a cryoprotectant for preventing deterioration. They must be stored in a freezer at temperatures from −80 °C to −15 °C. It is thought that therapeutic applications of this mRNA-LNP technology could be accelerated if a new formulation that permits mRNA-LNPs to be stored under milder conditions were available. We previously reported on a one-pot method for producing siRNA-encapsulated LNPs by combining freeze-drying technology with the conventional alcohol dilution method (referred to herein as the “alcohol dilution–lyophilization method”). In this study, this method was applied to the preparation of mRNA-LNPs to provide a freeze-dried formulation of mRNA LNPs. The resulting formulation can be stored at 4 °C for at least 4 months.
- 1 June 2022
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 142 (6) , 601-609
Compliance with Vaccination against SARS-CoV-2; Information Transmission Based on Scientific Evidence and Its Difficulty
The fight against coronavirus disease 2019 (COVID-19) in Japan began after January 2020. In order for the country to resume an active social life as a society, it is necessary to prevent an increase in the number of newly infected people with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), and to prevent aggravation and/or death after infection. Although several therapeutic agents have been developed to treat COVID-19 after infection, vaccination with SARS-CoV-2 is the most effective in controlling or even ending the COVID-19 pandemic in Japan. The Ministry of Health, Labour and Welfare has convened a council to publish the collected data on COVID-19 and to proceed with discussions for promoting safe and effective vaccination. However, no matter how we release to the public the scientific basis of our findings and proposed methods of prevention and treatment, there remain cases where false opinions have spread, and vaccinations are refused accordingly. This paper traces the course of the work of this council, and considers current challenges in communicating COVID-19 information to the public based on scientific evidence.
- 1 June 2022
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 142 (6) , 601-609
Compliance with Vaccination against SARS-CoV-2; Information Transmission Based on Scientific Evidence and Its Difficulty
The fight against coronavirus disease 2019 (COVID-19) in Japan began after January 2020. In order for the country to resume an active social life as a society, it is necessary to prevent an increase in the number of newly infected people with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), and to prevent aggravation and/or death after infection. Although several therapeutic agents have been developed to treat COVID-19 after infection, vaccination with SARS-CoV-2 is the most effective in controlling or even ending the COVID-19 pandemic in Japan. The Ministry of Health, Labour and Welfare has convened a council to publish the collected data on COVID-19 and to proceed with discussions for promoting safe and effective vaccination. However, no matter how we release to the public the scientific basis of our findings and proposed methods of prevention and treatment, there remain cases where false opinions have spread, and vaccinations are refused accordingly. This paper traces the course of the work of this council, and considers current challenges in communicating COVID-19 information to the public based on scientific evidence.
- 1 January 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1866 (1) , 158809
Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL
- 1 January 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1866 (1) , 158809
Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL
- Open Access
- 2 September 2019
- Published by Springer Nature in Journal of Pharmaceutical Health Care and Sciences
- Vol. 5 (1) , 1-7
Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
There is a lack of evidence that multidrug use triggers adverse events. Therefore, the main purpose of this study was to clarify the relationship between the total number of drugs and number of high-risk prescriptions administered to Japanese elderly patients. Using hospital electronic medical records (EMR), we evaluated the prescriptions of outpatients aged 65 years or older. We defined prescriptions of potentially inappropriate medications (PIMs) and overlapping prescription of drugs with the same mechanism of action (DSAs) as high-risk prescriptions. We analyzed the relationship among total number of drugs and high-risk prescriptions. In addition, we performed a secondary research to determine whether the hospitalization rate and concomitant medication contents differ depending on the high-risk prescriptions. Data for 13,630 outpatients were analyzed. A significant positive correlation between the numbers of total drugs and PIMs was found. The prescription frequency of individual PIMs rose as the total number of prescription drugs increased. The odds ratio (OR) of overlapping DSAs was significantly higher in patients using 5 or more drugs. In addition, there were significantly more prescriptions of laxatives among patients with overlapping prescriptions of anticholinergic drugs. The use of almost all PIMs was not an independent risk factor for hospitalization; instead, the number of PIMs was an independent risk factor for hospitalization [OR 1.18 (95% CI, 1.12–1.26)]. The number of PIMs and overlapping DSAs were high in patients receiving multidrug treatment. To avoid adverse events and hospitalization, it might be useful to review prescriptions and consider the number of PIMs and overlapping DSAs.
- 2 September 2019
- Published by Springer Nature in Journal of Pharmaceutical Health Care and Sciences
- Vol. 5 (1) , 1-7
Open AccessMultidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
There is a lack of evidence that multidrug use triggers adverse events. Therefore, the main purpose of this study was to clarify the relationship between the total number of drugs and number of high-risk prescriptions administered to Japanese elderly patients. Using hospital electronic medical records (EMR), we evaluated the prescriptions of outpatients aged 65 years or older. We defined prescriptions of potentially inappropriate medications (PIMs) and overlapping prescription of drugs with the same mechanism of action (DSAs) as high-risk prescriptions. We analyzed the relationship among total number of drugs and high-risk prescriptions. In addition, we performed a secondary research to determine whether the hospitalization rate and concomitant medication contents differ depending on the high-risk prescriptions. Data for 13,630 outpatients were analyzed. A significant positive correlation between the numbers of total drugs and PIMs was found. The prescription frequency of individual PIMs rose as the total number of prescription drugs increased. The odds ratio (OR) of overlapping DSAs was significantly higher in patients using 5 or more drugs. In addition, there were significantly more prescriptions of laxatives among patients with overlapping prescriptions of anticholinergic drugs. The use of almost all PIMs was not an independent risk factor for hospitalization; instead, the number of PIMs was an independent risk factor for hospitalization [OR 1.18 (95% CI, 1.12–1.26)]. The number of PIMs and overlapping DSAs were high in patients receiving multidrug treatment. To avoid adverse events and hospitalization, it might be useful to review prescriptions and consider the number of PIMs and overlapping DSAs.
- Open Access
- 5 January 2018
- Published by Taylor & Francis in Renal Failure
- Vol. 40 (1) , 43-50
The effect of cholesterol overload on mouse kidney and kidney-derived cells
Introduction: Dyslipidemia is one of the onset and risk factors of chronic kidney disease and renal function drop is seen in lipoprotein abnormal animal models. However, the detailed molecular mechanism of renal lipotoxicity has not been clarified. Therefore, the present study aimed to investigate the influence of cholesterol overload using mouse kidney tissue and kidney-derived cultured cells. Methods: C57BL/6 mice were fed normal diet (ND) or 1.25% cholesterol-containing high-cholesterol diet (HCD) for 11 weeks, and we used megalin as a proximal tubule marker for immunohistology. We added beta-very low density lipoprotein (βVLDL) to kidney-derived cells and examined the effect of cholesterol overload on megalin protein and mRNA expression level, cell proliferation and cholesterol content in cells. Results: In the kidney of HCD mice, the gap between glomerulus and the surrounding Bowman’s capsule decreased and the expression level of megalin decreased. After βVLDL treatment to the cells, the protein expression and mRNA expression level of megalin decreased and cell proliferation was restrained. We also observed an increase in cholesterol accumulation in the cell and free cholesterol/phospholipid ratios increased. Conclusions: These findings suggest that the increased cholesterol load on kidney contribute to the decrease of megalin and the overloaded cholesterol is taken into the renal tubule epithelial cells, causing suppression on cell proliferation, which may be the cause of kidney damage.
- 5 January 2018
- Published by Taylor & Francis in Renal Failure
- Vol. 40 (1) , 43-50
Open AccessThe effect of cholesterol overload on mouse kidney and kidney-derived cells
Introduction: Dyslipidemia is one of the onset and risk factors of chronic kidney disease and renal function drop is seen in lipoprotein abnormal animal models. However, the detailed molecular mechanism of renal lipotoxicity has not been clarified. Therefore, the present study aimed to investigate the influence of cholesterol overload using mouse kidney tissue and kidney-derived cultured cells. Methods: C57BL/6 mice were fed normal diet (ND) or 1.25% cholesterol-containing high-cholesterol diet (HCD) for 11 weeks, and we used megalin as a proximal tubule marker for immunohistology. We added beta-very low density lipoprotein (βVLDL) to kidney-derived cells and examined the effect of cholesterol overload on megalin protein and mRNA expression level, cell proliferation and cholesterol content in cells. Results: In the kidney of HCD mice, the gap between glomerulus and the surrounding Bowman’s capsule decreased and the expression level of megalin decreased. After βVLDL treatment to the cells, the protein expression and mRNA expression level of megalin decreased and cell proliferation was restrained. We also observed an increase in cholesterol accumulation in the cell and free cholesterol/phospholipid ratios increased. Conclusions: These findings suggest that the increased cholesterol load on kidney contribute to the decrease of megalin and the overloaded cholesterol is taken into the renal tubule epithelial cells, causing suppression on cell proliferation, which may be the cause of kidney damage.
- Open Access
- 22 November 2017
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 47 (6) , 495-496
The need for pharmacists in post‐disaster healthcare: a case from a developing country, Nepal
- 22 November 2017
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 47 (6) , 495-496
Open AccessThe need for pharmacists in post‐disaster healthcare: a case from a developing country, Nepal
- 6 December 2016
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 53 (3) , 191-198
Growth arrest of vascular smooth muscle cells in suspension culture using low-acyl gellan gum
The proliferation of vascular smooth muscle cells (SMCs) causes restenosis in biomaterial vascular grafts. The purposes of this study were to establish a suspension culture system for SMCs by using a novel substrate, low-acyl gellan gum (GG) and to maintain SMCs in a state of growth inhibition. When SMCs were cultured in suspension with GG, their proliferation was inhibited. Their viability was 70% at day 2, which was maintained at more than 50% until day 5. In contrast, the viability of cells cultured in suspension without GG was 5.6% at day 2. By cell cycle analysis, the ratio of SMCs in the S phase when cultured in suspension with GG was lower than when cultured on plastic plates. In SMCs cultured in suspension with GG, the ratio of phosphorylated retinoblastoma (Rb) protein to Rb protein was decreased and p27Kip1 expression was unchanged in comparison with SMCs cultured on plastic plates. In addition, SMCs could be induced to proliferate again by changing the culture condition from suspension with GG to plastic plates. These results suggest that our established culturing method for SMCs is useful to maintain SMCs in a state of growth inhibition with high viability.
- 6 December 2016
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 53 (3) , 191-198
Growth arrest of vascular smooth muscle cells in suspension culture using low-acyl gellan gum
The proliferation of vascular smooth muscle cells (SMCs) causes restenosis in biomaterial vascular grafts. The purposes of this study were to establish a suspension culture system for SMCs by using a novel substrate, low-acyl gellan gum (GG) and to maintain SMCs in a state of growth inhibition. When SMCs were cultured in suspension with GG, their proliferation was inhibited. Their viability was 70% at day 2, which was maintained at more than 50% until day 5. In contrast, the viability of cells cultured in suspension without GG was 5.6% at day 2. By cell cycle analysis, the ratio of SMCs in the S phase when cultured in suspension with GG was lower than when cultured on plastic plates. In SMCs cultured in suspension with GG, the ratio of phosphorylated retinoblastoma (Rb) protein to Rb protein was decreased and p27Kip1 expression was unchanged in comparison with SMCs cultured on plastic plates. In addition, SMCs could be induced to proliferate again by changing the culture condition from suspension with GG to plastic plates. These results suggest that our established culturing method for SMCs is useful to maintain SMCs in a state of growth inhibition with high viability.
- 18 February 2016
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 7 (1) , 31-36
Assessment of regulatory compliance in selected pharmacy outlets of Nepal
- 18 February 2016
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 7 (1) , 31-36
Assessment of regulatory compliance in selected pharmacy outlets of Nepal
- 1 January 2016
- Published by Elsevier in Microvascular Research
- Vol. 103, 36-40
p27 Kip1 and p21 Cip1 -independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs
- 1 January 2016
- Published by Elsevier in Microvascular Research
- Vol. 103, 36-40
p27 Kip1 and p21 Cip1 -independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs